ECSP003631A - NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAME - Google Patents
NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAMEInfo
- Publication number
- ECSP003631A ECSP003631A ECSP003631A ECSP003631A EC SP003631 A ECSP003631 A EC SP003631A EC SP003631 A ECSP003631 A EC SP003631A EC SP003631 A ECSP003631 A EC SP003631A
- Authority
- EC
- Ecuador
- Prior art keywords
- glutamic
- oxo
- amino
- procedures
- pirimidin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003432 anti-folate effect Effects 0.000 abstract 1
- 229940127074 antifolate Drugs 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000004052 folic acid antagonist Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente inevnción se refiere al campo de la quimica farmacéutica y orgánica y proporciona una nueva forma cristalina antifolato disódico de la sal del ácido n- n-[4-[2-amino-4,7-dihidro-4-oxo-3H-pirrolo[2,3-d]-pirimidin-5-il)etil]benzoil]-L-glutámico de ahora en adelante MTA) utilizado para múltiples propósitos y procedimientos para el mismo.The present inevitability refers to the field of pharmaceutical and organic chemistry and provides a new crystalline form disodium antifolate of the salt of the n- n- [4- [2-amino-4,7-dihydro-4-oxo-3H- Pyrrolo [2,3-d] -pyrimidin-5-yl) ethyl] benzoyl] -L-glutamic hereafter MTA) used for multiple purposes and procedures therefor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003631 ECSP003631A (en) | 2000-08-23 | 2000-08-23 | NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAME |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003631 ECSP003631A (en) | 2000-08-23 | 2000-08-23 | NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003631A true ECSP003631A (en) | 2001-03-22 |
Family
ID=42041235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003631 ECSP003631A (en) | 2000-08-23 | 2000-08-23 | NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAME |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003631A (en) |
-
2000
- 2000-08-23 EC ECSP003631 patent/ECSP003631A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2002000321A (en) | A NEW CRYSTAL FORM OF ACID N- [4- [2- (2- AMINO-4,7-DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] PIRIMIDIN -5-IL) ETIL] BENZOIL] - L-GLUTAMIC AND PROCEDURE FOR PREPARATION REF. X-11969 | |
| TW200831103A (en) | Crystalline forms of pemetrexed diacid and processes for the preparation thereof | |
| UY30136A1 (en) | SPECIFIC SALT, ANHYDRA AND CRYSTALLINE FORM OF A DIHYDROPTERIDION DERIVATIVE | |
| SI3106463T1 (en) | Substituted pyrazolo(1,5-)pyrimidine compounds as trk kinase inhibitors | |
| CR9505A (en) | ANHYDING CRYSTAL FORMS OF THE N- (1- (2-ETOXIETIL) -5- (N-ETIL-N-METHYLAMINE) -7- (4-METHYLPIRIDIN-2-IL-AMINO) -1H-PIRAZOLO (4,3- D) PYRIMIDINE-3-CABONIL) METHANOSULPHONAMIDE | |
| NO20035210L (en) | 2-anilino-pyrimidine derivatives as cyclin-dependent kinase inhibitors | |
| BR112012020557A8 (en) | crystalline forms of sodium 4 - {[9-chloro-7- (2-fluoro-6-methophenyl) -5h-pyrimido [5,4-d] [2] benzazepin-2-yl] amino} -2-methoxybenzoate | |
| BR0316680A (en) | Chk, pdk and akt inhibitor pyrimidines, their production and use as pharmaceutical agents | |
| CY1111061T1 (en) | NEW HYDROCYCLIC UNIONS ACTIVE AS BETA-LACTAMA INHIBITIONS | |
| PE20060372A1 (en) | CRYSTALLINE FORM OF (-) - (1R, 2R) -3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOL HYDROCHLORIDE | |
| GT200000170A (en) | THERAPEUTIC AGENTS. | |
| DK0738270T3 (en) | Dihydropyrazolopyrroles | |
| UY27222A1 (en) | PIRAZOLOPIRIMIDINAS AS THERAPEUTIC AGENTS | |
| PT1268445E (en) | 4-AMINO-5-CYANO-2-ANYLINO-PYRIMIDINE DERIVATIVES AND THEIR USE AS CELL CYCLE INHIBITORS | |
| UY27374A1 (en) | USE OF NK-1 RECEIVER ANTAGONISTS FOR THE TREATMENT OF BRAIN, SPINAL OR NEURONAL INJURIES | |
| UY29427A1 (en) | SUBSTITUTED DERIVATIVES OF 2,3,4,5- TETRAHIDRO-1H-PIRIDO (4,3-B) INDOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| PE20081556A1 (en) | GLYT1 CRYSTAL SHAPES | |
| BG108426A (en) | NEW DERIVATIVES OF SULFONIC ACID | |
| AR069325A1 (en) | PROCESS TO PREPARE DIBENZOIL SALTS - L - TARTRATO | |
| ATE433969T1 (en) | PYRIMIDINE COMPOUNDS | |
| PE20100084A1 (en) | PHARMACEUTICAL COMBINATION | |
| EA200600833A1 (en) | TIAZOLIDINONONY, THEIR RECEIVING AND APPLICATION AS PHARMACEUTICAL AGENTS | |
| AR041678A1 (en) | CRYSTAL FORMS OF DONEPEZIL CHLORHYDRATE | |
| NO20090332L (en) | 4-Amino-3-arylamino-6-arylpyrazole [3,4-D] pyrimidine derivatives, methods of their preparation and use as antiviral agents | |
| ECSP003631A (en) | NEW CRYSTAL FORM OF THE DISODIC ACID SALT N- [4- [2-AMINO-4,7 - DIHIDRO-4-OXO-3H-PIRROLO [2,3-D] -PIRIMIDIN-5-IL) ETIL] BENZOIL] -L-GLUTAMIC AND PROCEDURES FOR THE SAME |